We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+20.59%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$6.58B
AUM Growth
+$1.05B
Cap. Flow
-$25.9M
Cap. Flow %
-0.39%
Top 10 Hldgs %
40.89%
Holding
798
New
75
Increased
93
Reduced
219
Closed
57

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$39.4M
2
WEX icon
WEX
WEX
+$25.8M
3
BDX icon
Becton Dickinson
BDX
+$16.6M
4
ADBE icon
Adobe
ADBE
+$15.7M
5
MSFT icon
Microsoft
MSFT
+$14.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$58.1M
2
NVO
Novo Nordisk
NVO
+$26M
3
CL icon
Colgate-Palmolive
CL
+$12.7M
4
CTSH icon
Cognizant
CTSH
+$10.8M
5
CMI icon
Cummins
CMI
+$7.43M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 16.94%
3 Financials 11.08%
4 Consumer Discretionary 10.18%
5 Consumer Staples 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MS icon
401
Morgan Stanley
MS
$346B
$52K ﹤0.01%
1,233
-742
-38% -$31.2K
WASH icon
402
Washington Trust Bancorp
WASH
$761M
$52K ﹤0.01%
1,089
– –
XYL icon
403
Xylem
XYL
$28.2B
$52K ﹤0.01%
661
– –
BUD icon
404
AB InBev
BUD
$158B
$51K ﹤0.01%
610
-2,339
-79% -$180K
UNFI icon
405
United Natural Foods
UNFI
$2.92B
$51K ﹤0.01%
3,845
-90
-2% -$1.22K
BG icon
406
Bunge Global
BG
$21.6B
$50K ﹤0.01%
940
-60
-6% -$3.18K
GSK icon
407
GSK
GSK
$101B
$50K ﹤0.01%
960
– –
ITUB icon
408
Itaú Unibanco
ITUB
$81.8B
$50K ﹤0.01%
7,797
– –
TROW icon
409
T. Rowe Price
TROW
$23.9B
$50K ﹤0.01%
500
– –
AEG icon
410
Aegon
AEG
$13.9B
$48K ﹤0.01%
11,674
-4,161
-26% -$18.2K
AGN
411
DELISTED
Allergan plc
AGN
$45K ﹤0.01%
310
– –
DSX icon
412
Diana Shipping
DSX
$305M
$44K ﹤0.01%
22,542
– –
EWJ icon
413
iShares MSCI Japan ETF
EWJ
$23.2B
$42K ﹤0.01%
773
– –
LILA icon
414
Liberty Latin America Class A
LILA
$1.67B
$42K ﹤0.01%
3,402
-3,982
-54% -$46.4K
A icon
415
Agilent Technologies
A
$42.1B
$41K ﹤0.01%
514
– –
CSL icon
416
Carlisle Companies
CSL
$15.1B
$41K ﹤0.01%
335
-165
-33% -$19.1K
VXF icon
417
Vanguard Extended Market ETF
VXF
$32.3B
$41K ﹤0.01%
359
-956
-73% -$107K
WAB icon
418
Wabtec
WAB
$49.6B
$41K ﹤0.01%
561
-2,269
-80% -$164K
SIVB
419
DELISTED
SVB Financial Group
SIVB
$41K ﹤0.01%
186
– –
ORBC
420
DELISTED
ORBCOMM, Inc.
ORBC
$41K ﹤0.01%
6,000
– –
AZN icon
421
AstraZeneca
AZN
$244B
$40K ﹤0.01%
499
– –
VYGR icon
422
Voyager Therapeutics
VYGR
$200M
$40K ﹤0.01%
2,100
– –
CCI icon
423
Crown Castle
CCI
$31.7B
$39K ﹤0.01%
307
– –
HII icon
424
Huntington Ingalls Industries
HII
$12.9B
$39K ﹤0.01%
190
– –
WDAY icon
425
Workday
WDAY
$44.2B
$39K ﹤0.01%
200
– –
15 16
17
18 19

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Loring Wolcott & Coolidge Fiduciary Advisors held 798 positions worth $6.58B, up 19% from $5.53B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2019 filing shows 75 new, 93 increased, 219 reduced and 57 closed positions. Its largest new stake was MSCI: 33,790 shares worth $6.72M. The largest sale was Celgene Corp, an estimated $58.1M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2019 buy was MSCI: 33,790 shares worth $6.72M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Amazon in Q1 2019, an estimated $39.4M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $58.1M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Invesco Russell 1000 Low Beta Equal Weight ETF in Q1 2019, selling an estimated $1.18M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 41% of its $6.58B portfolio in Q1 2019.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 75 new positions and closed 57 in Q1 2019.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 19% quarter-over-quarter to $6.58B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2019, filed 8 Apr 2019.